Incyte gets FDA blessing for vitiligo pigment disease cream treatment

Delaware Business Now

Jul 19, 2022

Delaware-based Incyte reported that the U.S. Food and Drug Administration approved Opzelura (ruxolitinib) cream 1.5% for the topical treatment of nonsegmental vitiligo in adult and…